InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（2 笔）
内部人交易记录
其他已披露买入
3
已披露卖出
2
T+90 胜率
0%
T+90 平均收益
-9.0%
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Sr One Capital Management, Llc. Director active across 4 companies, notably Arcellx, Inc.. Cumulatively, 11 disclosures have been logged. Split: 3 buys · 2 sells. Total volume traded: €35.6m. History available since 11 May 2023. The latest transaction was filed on 1 May 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sr One Capital Management, Llc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
277,777 股@ US$18.000.29% mcap50.0% 占其流量Common StockSEC:0001193125-26-201887:5
标准退出：2026年7月30日 (T+90)
277,778 股@ US$18.000.29% mcap50.0% 占其流量Common StockSEC:0001193125-26-201887:2
标准退出：2026年7月30日 (T+90)
1,419,298 股Common StockSEC:0001193125-26-201887:0
489,486 股Common StockSEC:0001193125-26-201887:1
354,824 股Common StockSEC:0001193125-26-201887:3
489,486 股Common StockSEC:0001193125-26-201887:4
63,158 股@ US$19.00100.0% 占其流量Common StockSEC:0001193125-25-239153:0
标准退出：2026年1月7日 (T+90)
1,505,388 股Common StockSEC:0000950170-24-106978:0
430,578 股@ €0.5544100.0% 占其流量Common StockSEC:0001209191-23-056920:0
631,932 股@ US$45.00100.0% 占其流量Common StockSEC:0001209191-23-029610:0
1,550,309 股Common StockSEC:0001209191-22-008281:0
11 条申报中的 11 条
About Sr One Capital Management, Llc
SR ONE CAPITAL MANAGEMENT, LLC is a declarant with 11 filings in total. In the sampled recent filings, covering the period from 2022-02-10 to 2026-05-01, buys amount to EUR 9563277 and sells amount to EUR 26059898. The companies mentioned are Avalyn Pharma Inc., where the entity is listed as a 10% Owner, as well as Zenas BioPharma, Inc., Arcellx, Inc., and eFFECTOR Therapeutics, Inc.
